Clinical trial
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate…
NCT00284271 · University of Cologne, Other · Completed
Key facts
| NCT number | NCT00284271 |
|---|---|
| Title | Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma |
| Lead sponsor | University of Cologne, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin´s Lymphoma |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Adramycin, Procarbacine, Prednisone, Vincristine, Bleomycin, Erythropoietin beta |
| Enrollment | 65 |
| Start date | Jan 1, 2004 |
| Primary completion | Dec 1, 2005 |
| First posted | Jan 31, 2006 |
| Last update posted | Jul 29, 2011 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: